The Israeli company raised $16m to support its Augmented Respiration Technology, a novel approach for delivering oxygen directly into the venous system. The company expects to earn FDA clearance for first product by 2023.

Abbott expects the ongoing recovery of medical procedure volumes to continue even as new virus variants are causing COVID-19 cases to increase in some geographies.

Johnson & Johnson’s medical device sales were up nearly 60% year-over-year in the second quarter of 2021 while Abbott reported 51% growth in its device business, reflecting the recovery in procedure volumes since the worst days of the pandemic in mid-2020.

In this edition of Device Week, Medtech Insight’s Marion Webb reviews the huge number of digital health investments announced in 2021, including numerous SPAC deals. UK-based reporter Barnaby Pickering talks about Angle, a British liquid diagnostics company that has developed a novel approach to liquid diagnostics.

Pacific Biosciences has agreed to pay $600m upfront in cash and stock and up $200m in additional milestone payments to acquire Omniome. PacBio also announced a new private placement of common stock to raise $300m.

In this roundup feature focusing on the developments in digital health, we highlight the key news and announcements from June.